Medical Affairs Launch Readiness Diagnostic Review
Does your launch plan reflect local realities, resolve critical dependencies and demonstrate readiness beyond a completed checklist?
When launch milestones approach but key local conditions remain unresolved, the cause isn't always slow execution. It may lie in untested assumptions about market readiness or Medical capacity, or in unresolved cross-functional dependencies.
Point Lumina’s review
Point Lumina’s facilitated diagnostic review helps maximise Medical Affairs value by identifying operating model friction points and giving leaders clarity on where to focus effort, how to improve decisions, and how to deliver impact where it matters most.
Who is this service for?
For affiliate and regional Medical Affairs leaders, launch Medical leads, Medical Excellence teams and General Managers who need an independent view of Medical readiness and the local dependencies that could compromise execution.
What you gain
A clear leadership-level assessment of demonstrated Medical readiness, consequential gaps and assumptions requiring validation before the agreed launch milestone.
A view of where local diagnostic, referral, treatment, evidence or access conditions challenge the assumptions underpinning the launch plan.
An assessment of whether Medical responsibilities are executable within the available capabilities, capacity and timelines.
Clearer ownership of dependencies across Medical Affairs, Market Access, Commercial and other relevant functions.
Recommendations for aligning global deliverables with local adaptation requirements, including the time, resources, and accountability needed.
An independent assessment of whether focused intervention can resolve the gaps, or whether changes to the launch plan and supporting operating model are needed, is warranted.
Clear priorities for action before the next milestone, with proposed decision owners, deadlines and issues requiring further validation.
*Further strategic advice or implementation support is available separately, where useful. The review supports leadership judgement and does not replace formal approvals or accountability for launch decisions.
“Arnas translated the global strategy into the regional context, amplifying best practices and opportunities across the region while aligning with local realities.” — Country Medical Director, Pharmaceutical organisation, former colleague.